Halozyme Therapeutics | HALO - Ebitda





Ebitda Changement Date
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
Baxter International USD -447M 873M 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cytokinetics USD -169.32M 19.48M 2026-03
DBV Technologies USD -45.9M 12.42M 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
MannKind USD -3.05M 20.97M 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Pfizer USD 5.99B 5.23B 2026-03
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12